Table of Contents
Challenges in Antibacterial Drug Development
Francis P. Tally M.D. Background
Challenges in Antibacterial Drug Development Characteristics of the Drug
Challenges in Antibacterial Drug Development
Challenges in Antibacterial Drug Development Characteristics to Justify Development
Challenges in Antibacterial Drug Development Classification of New Antibacterial Drugs
Challenges in Antibacterial Clinical Protocol Development
Challenges in Antibacterial Drug Development Trial Design
Bacterial Causes of Pneumonia
Challenges in Antibacterial Drug Development Trial Design
Challenges in Antibacterial Drug Development Challenges of Selecting Delta for Clinical Trial
Challenges in Antibacterial Drug Development “Biocreep”
Challenges in Antibacterial Drug Development Delta – Related to Efficacy Rates in 1992
Challenges in Antibacterial Drug Development Impact of Small Delta
Challenges in Antibacterial Drug Development Opinion
Challenges in Antibacterial Drug Development Opinion
Challenges in Antibacterial Drug Development Opinion
Challenges in Antibacterial Drug Development Problems With IV Only Drugs
Challenges in Antibacterial Drug Development Opinion – Paradox of Higher Mortality Infections
Challenges in Antibacterial Drug Development Overall Conclusions on Delta
Challenges in Antibacterial Drug Development Overall Conclusions on Delta
|
Author: Francis P. Tally M.D.
|